Articles tagged "Outcome"

2019 American Transplant Congress
Eculizumab in Kidney Transplant Recipients with Atypical Hemolytic Uremic Syndrome – Single Center Experience
A. Bhalla, S. Alasfar, N. Alachkar
Division of Transplant Nephrology, Johns Hopkins Hospital, Baltimore, MD
*Purpose: Atypical hemolytic uremic syndrome (aHUS) is caused by genetic mutations of components of the alternative complement pathway in 60-70% of cases; and has a…
2019 American Transplant Congress
High Prevalence of Allergic Disorders but No Specific Immune Phenotype Pattern in Children Awaiting Transplantation
T. B. Kim¹, Y. Avitzur², L. Ionescu¹, U. Allen², S. Mital², B. Foster³, T. Blydt-Hansen⁴, L. Hamiwka⁵, P. Birk⁶, V. Phan⁷, S. Urschel¹
¹University of Alberta, Edmonton, AB, Canada, ²Hospital for Sick Children, Toronto, ON, Canada, ³McGill University, Montreal, QC, Canada, ⁴University of British Columbia, Vancouver, BC, Canada, ⁵University of Calgary, Calgary, AB, Canada, ⁶University of Manitoba, Winnipeg, MB, Canada, ⁷Université de Montréal, Montreal, QC, Canada
*Purpose: Allergic disorders (AD) occur more frequently in children after transplantation (Tx) compared to healthy children, reflecting an imbalance of the immune system in the…
2019 American Transplant Congress
Hypertrophy Prediction Model for Contralateral Kidney after Living Donation
K. Okumura¹, K. Tanaka², Y. Hidaka², M. Toyoda³, S. Uekihara³, A. Inadome⁴, H. Yokomizo², S. Yamanaga²
¹Department of Surgery, University of Pittsburgh, Pittsburgh, PA, ²Department of Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan, ³Department of Nephrology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan, ⁴Department of Urology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan
*Purpose: Compensation of contralateral kidney function is well established and many factors have been proposed as risk factors. There is no prediction model to estimate…
2019 American Transplant Congress
Case Series Of Total Laparoscopic-hand Assisted Living Donor Right Hepatectomy: First 19 Cases At A Single Center In Usa
P. N. Martins¹, B. Movahedi², D. Litwin², A. Bozorgzadeh²
¹Surgery, Division of Transplantation, University of Massachusett, Worcester, MA, ²Surgery, Division of Transplantation, University of Massachusetts, Worcester, MA
*Purpose: One of the major limitations of living-donor liver donation is the associated morbidity of the procedure. Although left and left-lateral hepatectomy has been performed…
2019 American Transplant Congress
Microcirculation Inflammation with TCMR is Associated with Poor Graft Outcomes in Kidney Transplant Recipients (KTRs) without ABMR
A. Cherukuri, S. Tandukar, S. Hariharan, R. Mehta
UPMC, Pittsburgh, PA
*Purpose: Glomerulitis (g) and peritubular capillaritis (ptc), defined as microcirculation inflammation lesions (MI), are a hallmark of ABMR in KTRs. Their significance in KTRs with…
2019 American Transplant Congress
Impact of the 2013 Change in Definition of Increased Risk Donors on Lung Transplant Outcomes
C. J. Lehr¹, R. Lopez², S. Arrigain², J. D. Schold², M. Valapour¹
¹Respiratory Institute, Cleveland Clinic, Cleveland, OH, ²Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
*Purpose: The definition for donors at “increased risk” for human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV) was updated in 2013 from…
2019 American Transplant Congress
Timing Matters: Improving Prediction of Hospital Readmission Post Kidney Transplantation
J. Hogan¹, M. Arenson¹, S. Adhikary², K. Li¹, X. Zhang¹, R. Zhang¹, J. Valdez³, J. Sun³, A. B. Adams¹, R. E. Patzer¹
¹Transplant Research Center, Department of Surgery, Emory University, Atlanta, GA, ²Transplant Research Center, Department of Surgery, Georgia Technology Institute, Atlanta, GA, ³Georgia Technology Institute, Atlanta, GA
*Purpose: Hospital readmission rates after kidney transplant (KTx) are high and readmission is associated with graft failure and mortality. Predictive models of post-transplant readmission have…
2019 American Transplant Congress
Impact of Transplant Surgery Advanced Practice Providers in the Management of Pancreas Transplant Recipients
E. A. Herriman, J. M. Sharp, K. J. Brown, J. R. Montgomery, J. C. Magee, J. D. Punch, R. S. Sung, K. J. Woodside
Section of Transplantation, Department of Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Transplant surgery advanced practice providers (APPs) roles and responsibilities vary widely between different transplant centers. In an effort to standardize care for the pancreas…
2018 American Transplant Congress
Cannabis Dependence or Abuse before and after Kidney Transplantation: Implications for Post-Transplant Outcomes
K. Lentine,¹ T. Alhamad,² N. Lam,³ A. Naik,⁴ F. Koraishy,¹ H. Randall,¹ D. Segev,⁵ V. Dharnidharka,² D. Brennan,⁵ B. Kasiske,⁶ R. Ouseph,¹ M. Schnitzler.¹
¹Saint Louis Univ, St. Louis; ²Washington Univ, St. Louis; ³Univ Alberta, Edmonton, Canada; ⁴Univ Michigan, Ann Arbor; ⁵Johns Hopkins, Baltimore; ⁶Hennepin County Med Ctr, Minneapolis.
Currently, transplant centers vary in screening practices for marijuana use and requirements for abstinence before kidney transplantationWe examined billing claims and linked SRTR data for…
2018 American Transplant Congress
Brincidofovir Was Used to Successfully Treat Adenovirus Infections in Solid Organ Transplant Recipients and Other Immunocompromised Patients
D. Florescu,¹ M. Grimley,² G. Papanicolaou,³ V. Prasad,⁴ E. Vainorius,⁵ G. Chittick,⁵ T. Brundage,⁵ G. Nichols.⁵
¹Univ Nebraska Med Center, Omaha; ²Cincinnati Children's Hosp Center, Cincinnati; ³Memorial-Sloan Kettering Cancer Center, New York; ⁴Pediatric BMT, Duke Univ Med Center, Durham, NC; ⁵Chimerix, Inc., Durham.
Background: Adenovirus (AdV) infections cause significant morbidity and mortality in immunocompromised patients. Brincidofovir (BCV) is an investigational antiviral drug with high in vitro potency against…